Some of today's most experienced medical device company entrepreneurs and investment managers serve on REVA Medical's Non-Executive Board of Directors to assist in leveraging the successful application of patented technologies.Show All
Chairman and CEO
Robert Stockman, the Company's co-founder, has served as its Chairman of the Board and director since 1999 and its Chief Executive Officer since August 2010. Mr. Stockman also serves as a director of HeartWare Limited/HeartWare International, Inc., a medical device company listed on ASX and NASDAQ, since December 2006. Mr. Stockman also serves as a board member for Systagenix Wound Management, Ltd., a privately held wound care company, and MuseAmi, Inc., a privately held advanced music software company that Mr. Stockman co-founded. Since 1999, Mr. Stockman has been the President and Chief Executive Officer of Group Outcome LLC, A US-based merchant banking firm which Mr. Stockman founded that deploys its capital and that of its financial partners in private equity and venture capital investments in medical technology companies. Mr. Stockman also co-founded Centrimed, Inc., an internet-based software company that was acquired by the Global Healthcare Exchange, LLC. He led the buyouts of Ioptex, an intraocular lens manufacturer, and two Johnson & Johnson divestitures, "A" Company Orthodontics, Inc. and Critikon Company, LLC, each of which was subsequently acquired. Prior to establishing Group Outcome LLC, Mr. Stockman spent 18 years with Johnston Associates, Inc. and Narragansett Capital Corporation, where he focused on venture capital investments and merger advisory work in the health care sector. Mr. Stockman holds a Bachelors Degree from Harvard College and a Master of Business Administration from The Amos Tuck School of Business at Dartmouth College, where he is a member of the Board of Overseers. Mr. Stockman also serves on several other private-company and non-profit boards.
DirectorBrian Dovey has served as a director of the Company since June 2001. Mr. Dovey has been a Partner of Domain Associates, LLC, a private venture capital management firm focused on the life sciences sector, since 1988. Since joining Domain Associates, LLC, he has served on the board of directors of over 35 private and public companies and has been the Chairman of five. Prior to joining Domain Associates, LLC, Mr. Dovey spent six years at Rorer Group, Inc., a New York Stock Exchange listed pharmaceutical and medical device company (now part of Sanofi-Aventis), including as President from 1986 to 1988. Previously, Mr. Dovey was President of Survival Technology, Inc., a start-up medical products company. Mr. Dovey also held management positions with Howmedica, Inc., Howmet Corporation, and New York Telephone Company. Mr. Dovey has served as both President and Chairman of the National Venture Capital Association. He is Chair of the Wistar Institute, a non-profit preclinical biomedical research company. Mr. Dovey serves on the board of directors and is also Chairman at the Center for Venture Education (Kauffman Fellows Program). He was also a former board member of the industry association representing the medical device industry, as well as the association representing consumer pharmaceuticals. Mr. Dovey currently sits on the board of directors of Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. Mr. Dovey has also served as a member of the board of directors for the following publicly traded companies over the past five years: Align Technology, Inc., Cardiac Science, Inc., and Neose Technologies, Inc. Mr. Dovey received his Bachelor of Arts from Colgate University and a Master of Business Administration from the Harvard Business School.
Anne Keating has served as a director of the Company since October 2010. Ms. Keating is currently a director of a number of ASX-listed companies in a range of different industries, including GI Dynamics, Inc., a U.S.-based medical device company, Ardent Leisure Limited, a general management service provider, and Goodman Group Limited (formerly Macquarie Goodman), a property development and management company. She is also a member of the Advisory Council of C.I.M.B. Australia. Ms. Keating is also a director for the Garvan Institute of Medical Research and an Inaugural Governor for the Cerebral Palsy Foundation. From 1993 to 2001, Ms. Keating held the position of General Manager, Australia for United Airlines, and from 1994 to 1998, she was also a Governor for the American Chamber of Commerce. She was also a Delegate to the Australian/American Leadership Dialogue for 14 years. Ms. Keating was an inaugural Board member for the Victor Chang Cardiac Research Institute for ten years and also served on the board of NRMA/Insurance/AIG for nine years. She has also held former directorships with Spencer Street Station Redevelopment Holdings Limited, Easy FM China Pty Ltd, Radio 2 CH Pty Ltd, and Workcover Authority of New South Wales.
DirectorGordon E. Nye has served as a director of the Company since 1999. He is a managing director of Group Outcome LLC, a US-based merchant banking firm which deploys its capital and that of its financial partners in private equity and venture capital investments in medical technology companies. He served as the Chief Executive Officer of Zeltiq Aesthetics, Inc., a medical device company, from September 2009 to April 2012. From August 2003 to July 2009, Mr. Nye served as general partner of Prism Venture Partners, a venture capital firm, where he was a member of the life sciences investment team. Prior to that time, he served as the Company's Chief Executive Officer from 2001 to 2003 and President and Chief Executive Officer of two former Johnson & Johnson divisions "A" Company Orthodontics, Inc. and Critikon Company, LLC after they were acquired in management buyouts. He has also held a variety of marketing, sales, and general management roles for L.A. Gear, Inc., Olin Ski Company, Inc., Reebok Ltd., and The Gillette Company. Mr. Nye has also served on the board of directors of Insulet, Inc., a medical device company, from 2004 to 2008. Mr. Nye received his Master of Business Administration from "The Amos Tuck School of Business" at Dartmouth College where he also received his undergraduate degree.
Robert Thomas has served as a director of the Company since July 2010. He has also been a director and non-executive Chairman of the board of HeartWare Limited/HeartWare International, Inc., a US medical device company listed on ASX and NASDAQ, since November 2004. Mr. Thomas is currently a director of a number of Australian public companies, including Virgin Australia Limited, Biotron Limited, and TAL Limited. Between October 2004 and September 2008, Mr. Thomas was a consultant to Citigroup Corporate and Investment Bank and was Chairman of Global and Corporate Investment Bank, Australia and New Zealand of Citigroup Global Markets Australia Pty Limited between March 2003 and September 2004. Prior to that time, Mr. Thomas was Chief Executive Officer of Citigroup's (formerly known as Salomon Smith Barney) Corporate and Investment Bank, Australia and New Zealand from October 1999 until February 2003. Mr. Thomas is Chairman of Aus Bio Limited, a director of O'Connell Street Associates and Grahger Capital Securities, and President of the State Library Council of New South Wales. Mr. Thomas holds a Bachelor of Economics from Monash University. He is currently Chairman of the Stockbrokers Association of Australia and is a Master Stockbroker. Mr. Thomas is also a Fellow of the Financial Services Institute of Australia and the Australian Institute of Company Directors.